The Impact of First-Line Anti-Tubercular Drugs’ Pharmacokinetics on Treatment Outcome: A Systematic Review
Tesemma Sileshi,1,2 Esayas Tadesse,1 Eyasu Makonnen,2 Eleni Aklillu3 1Ambo University, Department of Pharmacy, Ambo, Ethiopia; 2Addis Ababa University, College of Health Sciences, Addis Ababa, Ethiopia; 3Karolinska Institutet, Department of Laboratory Medicine, Stockholm, SwedenCorrespondence: Tesem...
Main Authors: | Sileshi T, Tadesse E, Makonnen E, Aklillu E |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-01-01
|
Series: | Clinical Pharmacology: Advances and Applications |
Subjects: | |
Online Access: | https://www.dovepress.com/the-impact-of-first-line-anti-tubercular-drugsrsquo-pharmacokinetics-o-peer-reviewed-article-CPAA |
Similar Items
-
Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies
by: Jan-Willem C. Alffenaar, et al.
Published: (2022-12-01) -
Effect of Genetic Variations in Drug-Metabolizing Enzymes and Drug Transporters on the Pharmacokinetics of Rifamycins: A Systematic Review
by: Sileshi T, et al.
Published: (2022-06-01) -
An in vitro ADME and in vivo Pharmacokinetic Study of Novel TB-Active Decoquinate Derivatives
by: Lloyd Tanner, et al.
Published: (2019-02-01) -
The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis
by: Ahmed A. Abulfathi, et al.
Published: (2021-06-01) -
Multidrug-resistant tubercular appendicitis: Report of a case
by: Afshin Moniri, et al.
Published: (2013-01-01)